Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.
about
My treatment approach to rheumatoid arthritisPatient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literatureReview: treat to target in rheumatoid arthritis: fact, fiction, or hypothesis?The Patient Global Assessment of Disease Activity in Rheumatoid Arthritis: Identification of Underlying Latent Factors.Sociodemographic, disease, health system, and contextual factors affecting the initiation of biologic agents in rheumatoid arthritis: a longitudinal studyDo claimants over-report behavioral health dysfunction when filing for work disability benefits?Reasons for discontinuation of subcutaneous biologic therapy in the treatment of rheumatoid arthritis: a patient perspectiveDeterminants of agreement between self-reported and parent-assessed quality of life for children in Germany-results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).How Do Perceptions of Asthma Control and Severity Relate to Indicators of Asthma Status and Treatment Recommendations by Pediatricians?Measures of arthritis activity associated with patient-reported improvement in rheumatoid arthritis when assessed prospectively versus retrospectively.A Multistakeholder Approach to Improving Quality in Rheumatoid Arthritis: Proceedings from the Rheumatoid Arthritis Quality Expert Medical Panel.Initial report of the osteogenesis imperfecta adult natural history initiative.Determinants of Disability in Rheumatoid Arthritis: A Community-Based Cohort Study.Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohortDiscordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivityUse of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs.Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain SetDeterminants of discordance in patients' and physicians' rating of rheumatoid arthritis disease activitySocioeconomic determinants of disability and depression in patients with rheumatoid arthritis.Prioritizing the patient: optimizing therapy in rheumatoid arthritis. Results of a patient questionnaire in northern Germany.Focus group interviews reveal reasons for differences in the perception of disease activity in rheumatoid arthritis.The Next Frontier in Communication and the ECLIPPSE Study: Bridging the Linguistic Divide in Secure Messaging.Pain, catastrophizing, and depression in the rheumatic diseases.Discordance Between Physician- and Patient-Reported Disease Severity in Adults with Atopic Dermatitis: A US Cross-Sectional Survey.Monitoring ankylosing spondylitis: clinically useful markers and prediction of clinical outcomes.Patient-Physician Discordance in Global Assessment in Rheumatoid Arthritis: A Systematic Literature Review With Meta-Analysis.Misalignment between physicians and patient satisfaction with psoriatic arthritis disease control.The Role of Psychosocial Processes in the Development and Maintenance of Chronic PainPatients' considerations in the decision-making process of initiating disease-modifying antirheumatic drugs.A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control.Psychosocial problems among newly diagnosed rheumatoid arthritis patients.Patient-physician discordance in global assessment in early spondyloarthritis and its change over time: the DESIR cohort.Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of actionThe Italian MacNew heart disease health-related quality of life questionnaire: a validation study.Patient-provider discordance between global assessments of disease activity in rheumatoid arthritis: a comprehensive clinical evaluation.Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.Discordant patient-physician assessments of disease activity and its persistence adversely impact quality of life and work productivity in US Hispanics with rheumatoid arthritis.Factors explaining the discrepancy between physician and patient global assessment of joint and skin disease activity in psoriatic arthritis patients.
P2860
Q26829955-1FEBEF1B-402B-4F7A-B351-33FAB7903C14Q28071844-F9A5D3D9-D8C2-4A31-9BBD-657E14C91CAEQ33577429-1D255C5B-B3B5-4C15-AF1F-CA737BB46DC7Q33725571-E026C85A-97D7-4F87-9094-37C2E5348B54Q34013509-2C81E4BC-326F-4BB3-A729-66B0CA4CB653Q34135620-0E0512FD-FBB9-4267-B84C-9ABFDD31725DQ35024257-74A8E765-855B-4622-B6C7-0204A22927F9Q35777102-90893A94-37D2-47F9-A3AB-7B9D16976053Q35836807-55567F4C-072F-446B-A127-1006FDF9C215Q36016066-8469636A-3F9A-4FD9-84D4-0B0EE3E21E41Q36266374-CDD42432-9081-402B-BC48-BCEEC9559B33Q36292806-304399DA-1732-4217-983C-26BE9A3BB521Q36542897-1ECB3A89-317A-41FD-BDAF-9B2D237AEC1DQ36552356-D21A54CA-6F62-4B6A-8EAB-447AD034F0F9Q36907691-4D9FDDE1-D61A-4A9D-9869-DAC1032BF3A3Q36923257-EF2F3F37-B5EE-49C6-BCD4-59C8D1F04EE8Q36943002-33267C7C-20AB-4F2D-96AC-5F6BBC1A7289Q36947638-D3A686DA-EBB1-4355-8C90-5F24C752584BQ36990607-2FB568EE-2DEA-41E5-91A9-87E9ED7DAF84Q37026956-21963470-7D3A-46BD-B7D7-0ADFE9DB739BQ37358286-70055028-88F4-40C7-A637-2C0F18941537Q37620064-6CD8DD17-B571-4BC9-9EF8-113F36403943Q37654371-9D9EC482-22FD-4E18-BD90-833D46E2DCAEQ37833903-97BDFEED-96DF-49A7-AD63-257479AE69E7Q38403506-A6757764-9517-4685-92FE-EE4FDFEFC545Q38517691-42BE2888-C381-4307-909D-F19614F340E4Q38802434-C5C220B1-CF55-4C9A-A064-F9D3ACD14C21Q38941723-903C708D-C9C7-4EC6-AC09-4C0B8806A598Q38944384-51652595-310D-4905-A656-AC5AF57BC08DQ39076719-C81AC778-8C9C-4371-A780-E2ACCDD01E85Q39325262-F9D319A8-8E77-4323-8737-3E2EB0DCDEFAQ39686381-A0F714CF-6B0E-453B-8B32-02EFDAF6190DQ40401248-BCFEAF08-032E-4AA3-9F97-D78BF7E9DAEDQ40664154-89F8E9BF-26D9-4843-989C-F5D8432AA76EQ41144274-237F9C1F-556B-41F2-B79C-675A3A8B0032Q41457720-CB9BA026-6281-4DC1-A44F-27F38BB11367Q41670046-FA1A4310-CEA3-4280-A531-0CDD60383725Q43867998-7FD4C29C-1636-4FD9-9EA6-9420FE007B89Q46074299-1EA7D0B0-0692-4B6A-AB08-072E7BAE741DQ46958700-A6706EE8-3894-4DD3-9A0D-7C9C0EA29111
P2860
Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Patient-physician discordance ...... erity in rheumatoid arthritis.
@ast
Patient-physician discordance ...... erity in rheumatoid arthritis.
@en
type
label
Patient-physician discordance ...... erity in rheumatoid arthritis.
@ast
Patient-physician discordance ...... erity in rheumatoid arthritis.
@en
prefLabel
Patient-physician discordance ...... erity in rheumatoid arthritis.
@ast
Patient-physician discordance ...... erity in rheumatoid arthritis.
@en
P2093
P2860
P356
P1476
Patient-physician discordance ...... erity in rheumatoid arthritis.
@en
P2093
David Glidden
Edward H Yelin
Jennifer L Barton
John Imboden
Jonathan Graf
P2860
P304
P356
10.1002/ACR.20132
P577
2010-06-01T00:00:00Z